Ann: End-of-Treatment Milestone Met in Phase 2 PTSD Trial, page-5

First 5 Last

Share
Profile

Follow
Inthecold

3 Posts.

09/07/18

13:52

Post #: 34228113
Share

Originally posted by doubledeckerdog ↑

The early patient trial results are only known to the company running the trial - not BNO - which I believe is arms length from BNO.

So, the company would not likely have much if any insight as to how the trials have gone in respect to those that were enrolled early and who have completed their assessments.

Anyway, BNO is not exactly renowned for the clarity of its announcements.

Wait and see......................

More interesting will be when we see how many options the Board awards the CEO for her glorious achievements this year - and that will be very interesting as there are no commercial successes to justify any payments at all......................

It would be wonderful to know what criteria they use for the award of such benefits.

Especially given the excessively generous base pay.

She has had a good stay at the trough - but if this PTSD trial is not a roaring success, then she will need to hope off the gravy train!!!

GLTA

Expand

Hi
I have to say the CEO is really approachable and clarified the notice in response to my query, it is only about the completion of the trial and in no way reflected aspects of the results- they will be completed later this quarter and announced.
So I am buying back the shares I sold this morning fearing a repeat of NRT.

BNO Price at posting: 51.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

AXP

Tambourah chases gold veins and mineralisation extension with drilling

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 2 more messages in this thread...

First 5 Last

Add BNO (ASX) to my watchlist

Ann: End-of-Treatment Milestone Met in Phase 2 PTSD Trial, page-5

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Tambourah chases gold veins and mineralisation extension with drilling

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Featured News